CME(CME)
CME
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $7.03B | $7.36B | $7.83B | $8.44B | $8.68B |
| Low | $6.96B | $7.01B | $7.80B | $8.17B | $8.40B |
| High | $7.14B | $7.70B | $7.86B | $8.67B | $8.91B |
| EBITDA Avg | $6.42B | $6.72B | $7.15B | $7.71B | $7.92B |
| Low | $6.35B | $6.40B | $7.12B | $7.46B | $7.67B |
| High | $6.52B | $7.03B | $7.17B | $7.92B | $8.13B |
| EBIT Avg | $6.31B | $6.61B | $7.02B | $7.58B | $7.79B |
| Low | $6.25B | $6.29B | $7.00B | $7.33B | $7.54B |
| High | $6.41B | $6.91B | $7.05B | $7.78B | $8.00B |
| Net Income Avg | $4.33B | $4.50B | $4.93B | $5.42B | $5.66B |
| Low | $4.29B | $4.30B | $4.72B | $5.20B | $5.42B |
| High | $4.54B | $4.93B | $5.13B | $5.61B | $5.86B |
| EPS Avg | $12.26 | $12.88 | $13.75 | $15.06 | $15.70 |
| Low | $11.90 | $11.93 | $13.11 | $14.43 | $15.05 |
| High | $12.60 | $13.70 | $14.23 | $15.59 | $16.25 |
| Analysts (Rev / EPS) | 11 / 9 | 11 / 9 | 8 / 3 | 7 / 1 | 7 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.72B | $1.70B | $1.74B | $1.88B | $1.87B | $1.81B | $1.85B | $2.04B |
| Low | $1.67B | $1.67B | $1.68B | $1.81B | $1.80B | $1.75B | $1.79B | $1.97B |
| High | $1.79B | $1.74B | $1.80B | $1.95B | $1.94B | $1.88B | $1.93B | $2.11B |
| EBITDA Avg | $1.57B | $1.55B | $1.58B | $1.71B | $1.70B | $1.65B | $1.69B | $1.86B |
| Low | $1.53B | $1.53B | $1.53B | $1.65B | $1.65B | $1.59B | $1.64B | $1.79B |
| High | $1.64B | $1.59B | $1.65B | $1.78B | $1.77B | $1.71B | $1.76B | $1.93B |
| EBIT Avg | $1.55B | $1.53B | $1.56B | $1.68B | $1.68B | $1.62B | $1.66B | $1.83B |
| Low | $1.50B | $1.50B | $1.50B | $1.63B | $1.62B | $1.57B | $1.61B | $1.76B |
| High | $1.61B | $1.56B | $1.62B | $1.75B | $1.74B | $1.68B | $1.73B | $1.90B |
| Net Income Avg | $1.08B | $1.08B | $1.08B | $1.21B | $1.18B | $1.16B | $1.15B | $1.34B |
| Low | $1.04B | $1.05B | $1.03B | $1.16B | $1.13B | $1.11B | $1.10B | $1.28B |
| High | $1.12B | $1.10B | $1.13B | $1.27B | $1.24B | $1.22B | $1.21B | $1.41B |
| EPS Avg | $2.98 | $2.97 | $2.96 | $3.34 | $3.24 | $3.19 | $3.17 | $3.69 |
| Low | $2.86 | $2.90 | $2.83 | $3.19 | $3.10 | $3.05 | $3.03 | $3.53 |
| High | $3.09 | $3.02 | $3.11 | $3.51 | $3.41 | $3.35 | $3.33 | $3.88 |
| Analysts (Rev / EPS) | 7 / 10 | 7 / 10 | 4 / 4 | 4 / 4 | 3 / 4 | 3 / 4 | 3 / 4 | 2 / 5 |